v3.25.2
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Product Information [Line Items]        
Equity method investment $ 7,233,000   $ 7,233,000
Federally insured limits 2,980,899   5,422,404 1,948,794
Inventory write-off 25,000   126,703  
Inventory non- current assets $ 196,315   $ 196,315
Product warranty Period 90 days   90 days  
Advertising costs $ 0 $ 0 $ 0 $ 0
Warrants [Member]        
Product Information [Line Items]        
Antidilutive shares   44,644 0 44,644
Employee Stock Options [Member]        
Product Information [Line Items]        
Antidilutive shares 475,368 1,387,775 606,452 1,387,775
Series D Convertible Preferred Stock [Member]        
Product Information [Line Items]        
Antidilutive shares 333,000 639,667 433,000 433,000
Series E Convertible Preferred Stock [Member]        
Product Information [Line Items]        
Antidilutive shares 5,172,416 4,541,667 5,172,416 3,833,334
Series F Convertible Preferred Stock [Member]        
Product Information [Line Items]        
Antidilutive shares     0 0
Minimum [Member]        
Product Information [Line Items]        
Product warranty Period 12 months   12 months  
Maximum [Member]        
Product Information [Line Items]        
Product warranty Period 36 months   36 months  
Patents [Member]        
Product Information [Line Items]        
Estimated useful life of intangible assets 17 years   17 years  
Customer 1 [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage 60.00% 31.00% 34.00% 48.00%
Customer 1 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage 89.00%   73.00% 83.00%
Customer 2 [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage   30.00% 31.00% 30.00%
Customer 2 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage     17.00% 11.00%
Customer 3 [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage 18.00% 26.00% 13.00% 11.00%
Customer 3 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage     10.00%  
Customer 4 [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage 11.00%   12.00%  
Three Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | UNITED STATES        
Product Information [Line Items]        
Concentration risk, percentage 14.00% 61.00% 45.00% 44.00%
Sawgrass Parent [Member]        
Product Information [Line Items]        
Deferred revenue $ 7,200,000      
Equity method investment     $ 7,200,000  
Asset Management Agreement [Member]        
Product Information [Line Items]        
Carrying value of common units received 7,200,000   7,200,000  
Deferred revenue     $ 7,200,000  
Equity method investment $ 7,200,000